SSY Group Ltd. | Balance Sheet

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
427
325
340
455
745
1,155
Total Accounts Receivable
1,060
703
935
857
1,231
1,271
Inventories
419
280
283
278
398
423
Other Current Assets
5
373
78
89
137
259
Total Current Assets
1,911
1,681
1,636
1,680
2,511
3,107
Net Property, Plant & Equipment
2,438
2,552
2,694
2,393
2,549
2,879
Total Investments and Advances
-
-
22
-
-
114
Long-Term Note Receivable
-
-
1
1
-
-
Intangible Assets
323
339
381
419
517
499
Other Assets
386
224
272
249
318
272
Total Assets
5,084
4,798
5,008
4,744
5,904
6,881
ST Debt & Current Portion LT Debt
869
508
688
633
900
Accounts Payable
354
288
270
174
194
Income Tax Payable
127
90
83
79
134
Other Current Liabilities
364
262
394
209
272
Total Current Liabilities
1,715
1,148
1,434
1,096
1,500
Long-Term Debt
455
364
1,125
935
848
Provision for Risks & Charges
-
9
-
-
-
Deferred Taxes
2
22
22
24
17
Other Liabilities
-
-
24
-
-
Total Liabilities
2,206
1,536
2,607
2,057
2,375
Common Equity (Total)
2,866
3,253
2,395
2,676
3,475
Total Shareholders' Equity
2,866
3,253
2,395
2,676
3,475
Total Equity
2,867
3,253
2,395
2,684
3,487
Liabilities & Shareholders' Equity
5,084
4,798
5,008
4,744
5,904
Accumulated Minority Interest
1
1
1
8
11
Non-Equity Reserves
11
8
6
3
42

About SSY Group

View Profile
Address
Rooms 4902-03, 49th Floor
Hong Kong
Hong Kong
Employees -
Website http://www.ssygroup.com.hk
Updated 07/08/2019
SSY Group Ltd. is an investment holding company, which engages in the research, development, and manufacture of pharmaceutical products. It operates through the following segments: Intravenous Infusion Solution and Others; and Medical Materials. The company was founded on September 28, 2004 and is headquartered in Hong Kong.